Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CNS PHARMACEUTICALS AG Launches New Website.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- CNS See Continuous net settlement.

CNS

See continuous net settlement (CNS).
 PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is proud to announce the launch of its new website for its flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation.  MemorA-Z[TM]. (http://www.memora-z.com/)

The new website for MemorA-Z[TM] represents another step towards the company's goal of establishing it's self as the leading worldwide provider of clinically proven supplements that support / maintain cognitive and other memory-related brain functions.

"We are pleased to be better able to serve our growing customer base with an enhanced direct to consumer experience for our clinically proven flagship product MemorA-Z[TM]. The product s developer Dr. John P. Blass research is solid, his credentials impeccable, and we look forward to aggressively marketing MemorA-Z[TM] as a timely answer to the worldwide concern of maintaining optimal brain output especially among baby boomers See generation X. ." - Samuel Weisberger, President of CNS PHARMACEUTICALS AG

The company firmly believes that if you are concerned about maintaining your mental sharpness, concentration and memory you should be taking MemorA-Z[TM] as the product represents the "next generation" of natural supplements. This fact is reinforced by a major study which utilized rigorous scientific standards such as an up-to-date prospective, double-blind process, a placebo controlled clinical trial controlled clinical trial,
n a research strategy that calls for two samples: an experimental sample of patients receiving a pharmaceutical, and a second sample of control patients receiving a placebo.
 with preset inclusion / exclusion criteria exclusion criteria AIDS Donor exclusion criteria, see there  and outcome variables. This study found that the MemorA-Z[TM] formulation effected statistically significant stabilization in memory function.

About: CNS PHARMACEUTICALS AG,

Based in Zurich, Switzerland, PHARMACEUTICALS AG , is the parent company of its 100%-owned U.S. subsidiary, CNS PHARMACEUTICALS INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. It trades under the symbol C35 on the Frankfurt Stock Exchange Frankfurt Stock Exchange

The largest of Germany's eight securities exchanges, operated by Deutsche Borse AS.
. (http://deutche-boerse.com ) www.cnsinvestor.com

CNS's Scientific Advisory Board includes world renowned scientists Dr. John Blass and Dr. Robert Shorr. John Blass, MD, Ph.D. was the First Chairman of the USA Joint Presidential-Congressional Panel on Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia.  and Related Disorders. He is Professor Emeritus at Weill Medical College of Cornell University and has published over 300 articles / studies on understanding and improving brain function with a focus on the aging. Robert Shorr, Ph.D. is a scientist and entrepreneur with more than 100 inventions and 150+ technical articles to his credit. Dr. Shorr is the CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  for Cornerstone Pharmaceuticals which is involved in developing an anti-cancer drug. Dr. Shorr is a highly respected member of the biotechnology and pharmaceutical science community.

About the Frankfurt Stock Exchange (FWB (Fixed Wireless Broadband) See fixed wireless. ):

FWB Frankfurter Wertpapierborse FWB Frankfurter Wertpapierborse

See Frankfurt Stock Exchange (FWB Frankfurter Wertpapierborse).
 (Frankfurt Stock Exchange) is one of the world's largest trading centers for securities. Operated by the Deutche Borse AG, FWB is the largest of the eight German Stock Exchanges. The Deutche Borse's products and services cover the entire process chain including securities and derivatives trading, transaction settlement, the provision of market information, as well as the development and operation of electronic trading systems. For more information, visit the Deutche Borse at: http://deutche-boerse.com

Information presented in this newsletter contain "forward looking statements" within the meaning of section 27A of the Securities act of 1933 and section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects'", "will," "anticipates," "estimates," "believes," "understands" or that by statements indicating certain actions "may," "could," or "might" occur.

382 Route 59 Airmont, N.Y. 10952 Tel: (877)-MEMORA-Z (877) 636-6729 Fax: (646)-219-7444

Website www.cnsinvestor.com E-mail: samuelweisberger@cnspharmaceuticals@yahoo.com
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Website overview
Date:Jul 9, 2009
Words:633
Previous Article:Brian McKnight Presents $20,000 "Maxell Song of the Year" to Matt Cusson Who, McKnight Says, "Has an Incredible Gift".
Next Article:TraceSpan Launches VDSL2 Lawful Interception System.
Topics:

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles